I've been trying to get them to look at the policy behind the FDA, and where the gaps might be...and the most likely outcomes.
Then this article pops up from Endpoints, basically verifying my views and ....
can we get them to focus on it, plus the Corp Comms issued on the same day as the Ann with the links in the Ann? (I even put highlights into excerpts from the Endpoints article)...
NO!!!
Meanwhile they lecture long and loud about processes that apply to other applications.
As if we're all idiots and they as technocrats are sooo wise.
It's so frustrating.
CEO Itescu needs to go, page-745
-
- There are more pages in this discussion • 169 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |